Decode Research Team
Biomarker selection for Epithalon research should be guided by its mechanism of action. General safety biomarkers include liver function (ALT, AST, bilirubin), renal function (creatinine, BUN), CBC, and a comprehensive metabolic panel at baseline and intervals. Specific pharmacodynamic biomarkers should be selected based on Epithalon's known receptor pharmacology. Appropriate positive control compounds should be included to validate assay sensitivity and confirm the research system is pharmacologically responsive.
⚠️ Please note: All peptides offered by Decode Peptides are strictly for research purposes only and are not intended for human consumption, medical treatment, or veterinary use. Always consult a licensed healthcare professional before making any health-related decisions.